245 related articles for article (PubMed ID: 33042279)
1. Intracellular calcium current disorder and disease phenotype in
Chen P; Xiao Y; Wang Y; Zheng Z; Chen L; Yang X; Li J; Wu W; Zhang S
Theranostics; 2020; 10(24):11215-11229. PubMed ID: 33042279
[TBL] [Abstract][Full Text] [Related]
2. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
3. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
4. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
[TBL] [Abstract][Full Text] [Related]
5. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the Role of Wnt and Rho Signaling Pathway in iPSC-Derived ARVC Cardiomyocytes by In Silico Mathematical Modeling.
Parrotta EI; Procopio A; Scalise S; Esposito C; Nicoletta G; Santamaria G; De Angelis MT; Dorn T; Moretti A; Laugwitz KL; Montefusco F; Cosentino C; Cuda G
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670616
[TBL] [Abstract][Full Text] [Related]
7. Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls.
Akdis D; Medeiros-Domingo A; Gaertner-Rommel A; Kast JI; Enseleit F; Bode P; Klingel K; Kandolf R; Renois F; Andreoletti L; Akdis CA; Milting H; Lüscher TF; Brunckhorst C; Saguner AM; Duru F
Heart Rhythm; 2016 Mar; 13(3):731-41. PubMed ID: 26569459
[TBL] [Abstract][Full Text] [Related]
8. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
[TBL] [Abstract][Full Text] [Related]
9. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis.
Te Riele AS; Agullo-Pascual E; James CA; Leo-Macias A; Cerrone M; Zhang M; Lin X; Lin B; Sobreira NL; Amat-Alarcon N; Marsman RF; Murray B; Tichnell C; van der Heijden JF; Dooijes D; van Veen TA; Tandri H; Fowler SJ; Hauer RN; Tomaselli G; van den Berg MP; Taylor MR; Brun F; Sinagra G; Wilde AA; Mestroni L; Bezzina CR; Calkins H; Peter van Tintelen J; Bu L; Delmar M; Judge DP
Cardiovasc Res; 2017 Jan; 113(1):102-111. PubMed ID: 28069705
[TBL] [Abstract][Full Text] [Related]
10. Deletion of obscurin immunoglobulin domains Ig58/59 leads to age-dependent cardiac remodeling and arrhythmia.
Grogan A; Coleman A; Joca H; Granzier H; Russel MW; Ward CW; Kontrogianni-Konstantopoulos A
Basic Res Cardiol; 2020 Sep; 115(6):60. PubMed ID: 32910221
[TBL] [Abstract][Full Text] [Related]
11. Impaired Intracellular Ca
Pierantozzi E; Szentesi P; Paolini C; Dienes B; Fodor J; Oláh T; Colombini B; Rassier DE; Rubino EM; Lange S; Rossi D; Csernoch L; Bagni MA; Reggiani C; Sorrentino V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163243
[TBL] [Abstract][Full Text] [Related]
12. Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy.
Li D; Liu Y; Maruyama M; Zhu W; Chen H; Zhang W; Reuter S; Lin SF; Haneline LS; Field LJ; Chen PS; Shou W
Hum Mol Genet; 2011 Dec; 20(23):4582-96. PubMed ID: 21880664
[TBL] [Abstract][Full Text] [Related]
13. Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy.
Zhang H; Liu S; Dong T; Yang J; Xie Y; Wu Y; Kang K; Hu S; Gou D; Wei Y
Sci Rep; 2016 Jun; 6():28101. PubMed ID: 27307080
[TBL] [Abstract][Full Text] [Related]
14. Arrhythmogenic Cardiomyopathy: the Guilty Party in Adipogenesis.
Stadiotti I; Catto V; Casella M; Tondo C; Pompilio G; Sommariva E
J Cardiovasc Transl Res; 2017 Dec; 10(5-6):446-454. PubMed ID: 28983804
[TBL] [Abstract][Full Text] [Related]
15. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
[TBL] [Abstract][Full Text] [Related]
16. Abnormal connexin43 in arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 mutations.
Fidler LM; Wilson GJ; Liu F; Cui X; Scherer SW; Taylor GP; Hamilton RM
J Cell Mol Med; 2009 Oct; 13(10):4219-28. PubMed ID: 18662195
[TBL] [Abstract][Full Text] [Related]
17. Integrin β1D Deficiency-Mediated RyR2 Dysfunction Contributes to Catecholamine-Sensitive Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy.
Wang Y; Li C; Shi L; Chen X; Cui C; Huang J; Chen B; Hall DD; Pan Z; Lu M; Hong J; Song LS; Zhao S
Circulation; 2020 May; 141(18):1477-1493. PubMed ID: 32122157
[TBL] [Abstract][Full Text] [Related]
18. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
[TBL] [Abstract][Full Text] [Related]
19. Novel OBSCN variants associated with a risk to exercise-intolerance and rhabdomyolysis.
Zemorshidi F; Töpf A; Claeys KG; McFarlane A; Patton A; Nafissi S; Straub V
Neuromuscul Disord; 2024 Jan; 34():83-88. PubMed ID: 38159459
[TBL] [Abstract][Full Text] [Related]
20. Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3β.
Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Domínguez F; Román M; Larrasa-Alonso J; Ortiz-Sánchez P; Martínez F; López-Olañeta M; Bonzón-Kulichenko E; Vázquez J; Martí-Gómez C; Santiago DJ; Prados B; Giovinazzo G; Gómez-Gaviro MV; Priori S; Garcia-Pavia P; Lara-Pezzi E
Circulation; 2019 Oct; 140(14):1188-1204. PubMed ID: 31567019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
